Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Assessment of Diffusion and Perfusion

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.

Blood cancer journal·2026

Same author

A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

Blood cancer discovery·2026

Same author

Beyond Static Subtypes in Large B-cell Lymphoma: Context, Plasticity, and Therapeutic Logic.

Blood cancer discovery·2026

Same author

Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab.

Blood advances·2026

Same author

Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.

American journal of hematology·2026

Same author

Assessing patient perspectives on enrollment in lymphoma clinical trials.

Cancer·2026

Search research articles

Related Experiment Video

Updated: Apr 5, 2026

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Next-generation prognostic assessment for diffuse large B-cell lymphoma.

Ashley D Staton¹, Jean L Koff¹, Qiushi Chen²

¹Department of Hematology & Medical Oncology, Emory University, Atlanta, GA 30322, USA.

Future Oncology (London, England)

|August 21, 2015

Summary

New prognostic models for diffuse large B-cell lymphoma (DLBCL) will improve patient stratification for targeted therapies. Integrating genetic, clinical, and epidemiologic data is key for future risk-adapted treatment strategies.

Keywords:

Cox regression models activated B cells diffuse large B-cell lymphoma gene-expression profiling logistic regression molecular subtyping risk prediction models

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Related Experiment Videos

Last Updated: Apr 5, 2026

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Area of Science:

Hematology
Oncology
Genetics

Background:

Standard therapy for diffuse large B-cell lymphoma (DLBCL) offers high cure rates, but relapse necessitates effective salvage options like autologous stem cell transplant.
Accurate prognostication is crucial for optimizing treatment and identifying patients who may benefit from novel therapeutic approaches.
Existing prognostic models require enhancement to better stratify DLBCL patients for risk-adapted strategies.

Purpose of the Study:

To review the significance of host genetic and tumor genomic alterations in DLBCL for risk stratification.
To discuss the integration of clinical and epidemiologic factors into prognostic models for DLBCL.
To highlight the need for large-scale data and novel modeling approaches for future DLBCL prognostication.

Main Methods:

Literature review focusing on host genetics, tumor genomics, clinical factors, and epidemiologic data in DLBCL.
Analysis of current and future directions in DLBCL risk stratification and prognostic model development.
Discussion of data requirements and methodological advancements for predictive modeling.

Main Results:

Host genetic and tumor genomic alterations are significant contributors to DLBCLpathogenesis and prognosis.
Clinical and epidemiologic factors provide valuable insights for patient risk stratification.
Integration of diverse data types is essential for developing robust prognostic algorithms.

Conclusions:

Next-generation prognostic models for DLBCL will leverage multi-factorial data, including genetic and clinical information, for improved patient stratification.
Future model development requires substantial patient data and advanced statistical techniques to achieve sufficient power for outcome prediction.
Novel modeling approaches hold promise for enhancing the accuracy and utility of DLBCL prognostic tools.